NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for mitomycin


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients
2009 NOV 16 ... 83 patients with intermediate or high-risk bladder tumors were randomized to receive Mitomycin-C alone (n = 41) or combined with hyperthermia (n = 42), following bladder conserving ...
Subject: BSD Medical Corporation
Price: $3.00
*
Investigators at Columbia University release new data on DNA research
2009 NOV 9 ... crosslinks (ICLs) are the most toxic lesions induced by chemotherapeutic agents such as mitomycin C and cisplatin. By covalently linking both DNA strands, ICLs prevent DNA melting, ...
Subject: DNA Research
Price: $3.00
*
New data from O. Nativ et al illuminate research in bladder cancer
2009 NOV 1 ... We evaluated the efficacy of combined bladder wall hyperthermia and intravesical mitomycin C instillation (thermo-chemotherapy) in cases of recurrence after bacillus ...
Subject: Bladder Cancer
Price: $3.00
*
New findings from F.H. Yuan and co-researchers in the area of fanconi anemia described
2009 NOV 1 ... with FANCD2 and partially with proliferating cell nuclear antigen irrespective of mitomycin C treatment. An increased number of FANCI foci form and become resistant to Triton X ...
Subject: Fanconi Anemia
Price: $3.00
*
New glaucoma study results reported from N. Anand et al
2009 NOV 2 ... the long-term comparative outcomes for needle revision with 5-fluorouracil (5-FU) and mitomycin C (MMC) of failed trabeculectomy blebs. A retrospective database search was made for all ...
Subject: Glaucoma
Price: $3.00
*
New keratectomy data have been reported by J.J.K. Ma and co-authors
2009 OCT 14 ... which extended below Bowman membrane. PTK was performed with a transepithelial ablation, mitomycin C (MMC), and a slightly myopic photorefractive keratectomy. Slit-lamp examination and ...
Subject: Keratectomy
Price: $3.00
*
New life sciences findings from C. Wirtz and co-researchers published
2009 NOV 23 ... determinants: the phage life-cycle and the host chromosomal background." "Mitomycin C induction of PVL-encoding prophages from different community-acquired MRSA strains led ...
Subject: Life Sciences
View Free
Daily News
Article
New neuroendocrine cancer study findings have been published by scientists at Goethe University
2009 NOV 2 ... the effectiveness of hepatic transarterial chemotherapy using two therapeutic protocols-mitomycin C alone and combined mitomycin C and gemcitabine-on ...
Subject: Neuroendocrine Cancer
Price: $3.00
*
Recent findings from R. Avisar and co-authors highlight research in pterygium
2009 OCT 13 ... recent study, researchers in Israel conducted a study "To determine if the timing of mitomycin C (MMC) application during pterygium surgery affects endothelial cell loss. A ...
Subject: Pterygium
Price: $3.00
*
Report summarizes glaucoma study findings from M. Ciancaglini and co-researchers
2009 NOV 2 ... (IVCM) of bulbar conjunctiva in glaucomatous patients undergoing trabeculectomy with mitomycin C in order to elucidate modifications. Fifteen eyes of 15 consecutive Caucasian patients ...
Subject: Glaucoma
Price: $3.00
*
Reports summarize genetics study results from University of South Carolina
2009 NOV 9 ... bands obtained after 1-D SDS-PAGE of co-precipitation eluates from cell extracts of mitomycin C treated and untreated mouse embryonic fibroblasts. Profiling of the interacting ...
Subject: Genetics
Price: $3.00
*
Researchers from Rhode Island Hospital describe findings in hepatectomy
2009 NOV 1 ... "This report describes a rapid liver repopulation protocol using mitomycin C (MMC) to block proliferation of rat hepatocytes in response to PH. One week post-MMC ...
Subject: Hepatectomy
Price: $3.00
*
Researchers from Shanghai University of Traditional Chinese Medicine, Research Center publish findings in breast cancer therapy
2009 NOV 2 ... Current study results from the report, 'Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts,' ...
Subject: Breast Cancer Therapy
Price: $3.00
*
Researchers from University of Crete, Division of Basic Sciences discuss findings in cancer gene therapy
2009 NOV 2 ... the cytotoxic effects of the chemotherapeutic agents 5-fluorouracil, cis-platin and mitomycin C. Soluble CD40L is produced by RAd-hCD40L transduced carcinoma cells but unlike other ...
Subject: Cancer Gene Therapy
Price: $3.00
*
Scientists at Baylor College of Medicine, College of Medicine discuss research in keratectomy
2009 OCT 13 ... the outcomes of wavefront-guided photorefractive keratectomy (WG PRK) using prophylactic mitomycin C (MMC) in eyes that had previously undergone radial keratotomy (RK). Retrospective, ...
Subject: Keratectomy
Price: $3.00
*
Studies from Jiangsu University add new findings in the area of non-small cell lung cancer
2009 NOV 9 ... or stage IIIB (T4 N1-2 M0) NSCLC received 2 cycles of chemotherapy with cisplatin, mitomycin, and vindesine, subsequent radiation therapy (45 Gy, twice-daily 1.5 Gy) with ...
Subject: Non-Small Cell Lung Cancer
Price: $3.00
*
University of Vienna publishes research in life sciences
2009 OCT 12 ... investigated in vitro. MCF-7 cells were treated with GEN (5 mu mol or 40 mu mol) and/or mitomycin C (MMC; 2.5 mu mol)." "For testing a possible radiosensitizing and ...
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login